InnoStars Talks

In this episode of InnoStars Talks , we sit down with Neringa Šeperienė , co-founder and CEO of BrachyDOSE , a Lithuanian medtech startup reinventing how clinicians measure radiation during brachytherapy. Her team has developed a flexible, single-use sensor paired with predictive algorithms — offering oncologists real-time dose data, fewer side effects, and a smoother clinical workflow. 👉 What do...

In this episode of  InnoStars Talks , we speak with  Milena Argirovic , Country Head at Takeda for Serbia, Albania, North Macedonia, Kosovo, and Montenegro. We explore how a region often seen as “lagging behind” is becoming a testing ground for bold innovation, data-driven solutions, and global partnerships. 👉 Can Big Pharma be truly agile? 👉 Why is Serbia a perfect pilot for the European Health...

Can technology save lives? In our latest episode of InnoStars Talks with Lehel Ferenczi from GE Healthcare we tell the real story behind AI in diagnostics, treatment, and prediction - and why trust is the final frontier. From early cancer detection to smarter ultrasound tools, this conversation reveals how data, design, and discipline are reshaping patient care—one algorithm at a time.

How can technology combat the global threat of counterfeit medicines?   Monika Stepanova, CEO and co-founder of Lightly Technologies, shares how her Czech start-up is pioneering a portable solution to detect fake drugs—helping law enforcement agencies and public health authorities tackle a crisis that is rapidly escalating worldwide. Discover how Lightly Technologies’ patented UV fingerprinting me...

How can we prepare future healthcare professionals for a rapidly evolving industry? Dr Rita Rocha, Coordinator of the Innovation and Value Creation Office at NOVA Medical School, shares how the institution is redefining medical education by fostering technology literacy, data analysis, ethical decision-making, and innovation. Discover how NOVA’s global partnerships—including Harvard Medical School...

📣 Congratulations to  Moodmon , the project led by the Polish company  Britenet , an InnoStars partner, for being awarded €1 million in funding through  EIT Health ’s prestigious Flagship Call. With the support of a distinguished European consortium, they are now set to obtain a CE mark, conduct clinical trials, and showcase its real-world healthcare benefits. Additionally, the team is working on...

🎙️ Join us for the third episode of InnoStars Talks, an engaging podcast series presented by EIT Health in partnership with Emerging Europe! Get ready for insightful discussions with health innovators transforming the medical landscape. 👥 In our latest episode, we speak with Jan Beger of GE Healthcare. Tune in as he talks about why and how to equip healthcare professionals with the skills they ne...

🎙️ Join us for the second episode of InnoStars Talks, an engaging podcast series presented by EIT Health in partnership with Emerging Europe! Get ready for insightful discussions with health innovators transforming the medical landscape. 👥 In our latest episode, we feature Maurizio Ferrari from SYNLAB Italia. Tune in as he shares his journey and the groundbreaking advancements in diagnostic bioma...

👥 In our first episode, Andrew Wrobel talks with Mate Balazs Kovacs, CEO and co-founder of AIPLabs, about his groundbreaking journey in combating skin diseases with AI-enhanced digital healthcare solutions. AIP Labs, the InnoStars Partner from Hungary is an artificial intelligence development company, which created a digital hospital ecosystem. Its first dermatology module, AIP Derm, is up and ru...

In this episode, Balázs Fürjes invites to a chat with Professor Krzysztof Klincewicz from the Faculty of Management at Warsaw University. The discussion, hosted by Andrew Wrobel focuses on the importance of collaborative innovation in boosting innovation in the European Union, particularly in countries with moderate or modest innovation scores. Don't forget to visit our website at  eithealth....

In this episode, Balázs Fürjes invites to a chat with Professor Guido Boella, Vice-Rector for Enterprises at the University of Turin.  The discussion, hosted by Andrew Wrobel focuses on the role of digital innovation hubs in strengthening innovation in the European Union, particularly in countries with moderate or modest innovation scores. Don't forget to visit our website at  eithealth....

When the Covid-19 pandemic hit, health tech stepped up, with what appeared to be 10 years’ worth of innovation occurring in 10 weeks. But, while the pandemic encouraged more partnerships and collaboration in the sector, it has also brought about multiple challenges for start-ups, such as making it more difficult to complete clinical validation through sourcing hardware or delaying the implementati...

This year a total of 36 teams from all over Europe showcased their budding start-ups in front of a jury of experts and potential investors, competing for a prize pool of 160,000 euros. The flagship programme of the European Institute of Innovation and Technology (EIT), EIT Jumpstarter is a pre-accelerator programme led by EIT Health and involving other EIT Knowledge and Innovation Communities (KIC...

Success in precision medicine depends on accessing high-quality genetic and molecular data that, in conjunction with comprehensive clinical data, can lead to more effective therapies. Although omics data is available on public databases, doctors are not yet able to extract useful value from it owing to its sheer volume and heterogeneity. While there are solutions to this problem - based...

Spastic hand paralysis is a painfully common problem experienced by patients who have suffered damage to the central nervous system due to a stroke or other causes. These patients are not able to autonomously open their fingers, which significantly impacts quality of life. There are about 20 million people suffering from hand spasticity worldwide, out of which 1.3 million people live in Europ...

EIT Health Spain has had a particularly fruitful 2020 in terms of health innovation projects.  In this episode,  Balázs Fürjes   speaks with Cristina Bescos, managing director at EIT Health Spain . Cristina holds a PhD in Biomedical Engineering and has a long career in research and management of large international teams in digital health and healthcare transformation, combining exp...

Leg length discrepancy (LLD) is an orthopaedic condition that involves a difference in length between the lower extremities. This is a significant medical problem, and the causes may be various trauma, diseases, deformities of the locomotor system, surgery, growth disorders, neurological illness, and others. Statistics have shown that up to 90 per cent of the population has LLD. Croatian start-up...

Mild cognitive impairment (MCI) is a precursor to Alzheimer’s disease (AD), the most common form of dementia. MCI contributes to 60–70 per cent of dementia cases, an illness for which there is currently no cure. However, very early-stage existing therapies can improve and prolong cognitive function.   Neus is a software solution for detecting MCI that combines eye-tracking technology, digital...

Monitoring the effects that drugs have on liver tissue is one of the primary tests used in the early phases of drug development and toxicological screening. Today, hepatotoxicity is tested either on cell lines (in vitro) or laboratory animals. But the current solutions are not delivering a long-term culture of human primary hepatocytes and are still dependent on cell lines (cancer cells) and anima...

Attention-deficit hyperactivity disorder (ADHD) is prevalent in people of all ages. Children and adults with ADHD frequently experience social exclusion as the society around them reacts negatively to their inability to understand and abide by the prevailing “social code”. It is currently estimated that up to five per cent of school-age children are affected by ADHD. The majority of...

Mental health is the main medical area in which routine decision-making for diagnoses and treatment choices is primarily based on clinical interviews and observations. Despite the availability of internationally accepted diagnostic and treatment guidelines, the adherence among clinicians to these standards in mental health is low, what is reflected by high rates of misdiagnosis and mistreatment. T...

Did you know that in 2018, one in five men was diagnosed with prostate cancer?  Currently, the PSA test is used as a biomarker of the disease, but it has low sensitivity and specificity, increased risk of false-positives and it cannot differentiate between benign and aggressive cancer.  The Stockholm3 test, on the other hand, is a blood test that can predict the risk of aggressive diseas...

The first episode of Healthcare Hackers presents FRADE , which stands for Pervasive Platform for Fall Risk Assessment. FRADE is the result of a partnership between Fraunhofer Portugal and the Higher School of Nursing of Porto, with the involvement of the University of Porto — an EIT Health Hub. Joana Silva , who is a biomedical researcher at Fraunhofer Portugal AICOS and manages the FRADE project,...